View Item 

Show simple item record

The S troke H yperglycemia I nsulin N etwork E ffort ( SHINE ) trial protocol: a randomized, blinded, efficacy trial of standard vs. intensive hyperglycemia management in acute stroke
dc.contributor.authorBruno, Askielen_US
dc.contributor.authorDurkalski, Valerie L.en_US
dc.contributor.authorHall, Christiana E.en_US
dc.contributor.authorJuneja, Rattanen_US
dc.contributor.authorBarsan, William G.en_US
dc.contributor.authorJanis, Scotten_US
dc.contributor.authorMeurer, William J.en_US
dc.contributor.authorFansler, Amyen_US
dc.contributor.authorJohnston, Karen C.en_US
dc.date.accessioned2014-02-11T17:57:25Z
dc.date.available2015-04-01T19:59:07Zen_US
dc.date.issued2014-02en_US
dc.identifier.citationBruno, Askiel; Durkalski, Valerie L.; Hall, Christiana E.; Juneja, Rattan; Barsan, William G.; Janis, Scott; Meurer, William J.; Fansler, Amy; Johnston, Karen C. (2014). "The S troke H yperglycemia I nsulin N etwork E ffort ( SHINE ) trial protocol: a randomized, blinded, efficacy trial of standard vs. intensive hyperglycemia management in acute stroke." International Journal of Stroke (2): 246-251.en_US
dc.identifier.issn1747-4930en_US
dc.identifier.issn1747-4949en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/102726
dc.publisherWileyen_US
dc.subject.otherProtocolsen_US
dc.subject.otherHyperglycemiaen_US
dc.subject.otherClinical Trialen_US
dc.subject.otherCerebral Infarctionen_US
dc.subject.otherAcute Ischemic Strokeen_US
dc.titleThe S troke H yperglycemia I nsulin N etwork E ffort ( SHINE ) trial protocol: a randomized, blinded, efficacy trial of standard vs. intensive hyperglycemia management in acute strokeen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/102726/1/ijs12045.pdf
dc.identifier.doi10.1111/ijs.12045en_US
dc.identifier.sourceInternational Journal of Strokeen_US
dc.identifier.citedreferenceWong AA, Schluter PJ, Henderson RD, O'Sullivan JD, Read SJ. Natural history of blood glucose within the first 48 hours after ischemic stroke. Neurology 2008; 70: 1036 – 1041.en_US
dc.identifier.citedreferencede Courten‐Myers GM, Kleinholz M, Wagner KR, Myers RE. Normoglycemia (not hypoglycemia) optimizes outcome from middle cerebral artery occlusion. J Cereb Blood Flow Metab 1994; 14: 227 – 236.en_US
dc.identifier.citedreferenceMeden P, Andersen M, Overgaard K, Rasmussen RS, Boysen G. The effects of early insulin treatment combined with thrombolysis in rat embolic stroke. Neurol Res 2002; 24: 399 – 404.en_US
dc.identifier.citedreferenceZhu CZ, Auer RN. Optimal blood glucose levels while using insulin to minimize the size of infarction in focal cerebral ischemia. J Neurosurg 2004; 101: 664 – 668.en_US
dc.identifier.citedreferenceNtaios G, Egli M, Faouzi M, Michel P. J‐shaped association between serum glucose and functional outcome in acute ischemic stroke. Stroke 2010; 41: 2366 – 2370.en_US
dc.identifier.citedreferenceMalmberg K, Ryden L, Efendic S et al. Randomized trial of insulin‐glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995; 26: 57 – 65.en_US
dc.identifier.citedreferenceVan den Berghe G, Wilmer A, Hermans G et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354: 449 – 461.en_US
dc.identifier.citedreferenceBruno A, Kent TA, Coull BM et al. Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial. Stroke 2008; 39: 384 – 389.en_US
dc.identifier.citedreferenceJohnston KC, Hall CE, Kissela BM, Bleck TP, Conaway MR. Glucose regulation in acute stroke patients (GRASP) trial: a randomized pilot trial. Stroke 2009; 40: 3804 – 3809.en_US
dc.identifier.citedreferenceAdams HP Jr, del Zoppo G, Alberts MJ et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007; 38: 1655 – 1711.en_US
dc.identifier.citedreferenceGray CS, Hildreth AJ, Sandercock PA et al. Glucose‐potassium‐insulin infusions in the management of post‐stroke hyperglycaemia: the UK glucose insulin in stroke trial (GIST‐UK). Lancet Neurol 2007; 6: 397 – 406.en_US
dc.identifier.citedreferenceKreisel SH, Berschin UM, Hammes HP et al. Pragmatic management of hyperglycaemia in acute ischaemic stroke: safety and feasibility of intensive intravenous insulin treatment. Cerebrovasc Dis 2009; 27: 167 – 175.en_US
dc.identifier.citedreferenceWalters MR, Weir CJ, Lees KR. A randomised, controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute ischaemic stroke patients. Cerebrovasc Dis 2006; 22: 116 – 122.en_US
dc.identifier.citedreferenceAdams HP, Jr, Leclerc JR, Bluhmki E, Clarke W, Hansen MD, Hacke W. Measuring outcomes as a function of baseline severity of ischemic stroke. Cerebrovasc Dis 2004; 18: 124 – 129.en_US
dc.identifier.citedreferenceAdams HP, Jr, Effron MB, Torner J et al. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: abciximab in emergency treatment of stroke trial (AbESTT‐II). Stroke 2008; 39: 87 – 99.en_US
dc.identifier.citedreferenceBruno A, Waddell MJ, Potter DJ et al. Opportunity to lower hyperglycaemia faster in patients with acute ischaemic stroke and diabetes. Int J Stroke 2010; 5: 338 – 339.en_US
dc.identifier.citedreferenceZhao W, Hill MD, Palesch Y. Minimal sufficient balance – a new strategy to balance baseline covariates and preserve randomness of treatment allocation. Stat Methods Med Res 2012, doi: 10.1177/0962280212436447.en_US
dc.identifier.citedreferenceHu F, Rosenberger WF. The Theory of Response Adaptive Randomization in Clinical Trials. New York, Wiley, 2006.en_US
dc.identifier.citedreferenceJuneja R, Roudebush C, Kumar N et al. Utilization of a computerized intravenous insulin infusion program to control blood glucose in the intensive care unit. Diabetes Technol Ther 2007; 9: 232 – 240.en_US
dc.identifier.citedreferenceTowler DA, Havlin CE, Craft S, Cryer P. Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms. Diabetes 1993; 42: 1791 – 1798.en_US
dc.identifier.citedreferenceWilliams LS, Weinberger M, Harris LE, Biller J. Measuring quality of life in a way that is meaningful to stroke patients. Neurology 1999; 53: 1839 – 1843.en_US
dc.identifier.citedreferenceThe National Institute of Neurological Disorders and Stroke rt‐PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581 – 1587.en_US
dc.identifier.citedreferencePalesch YY, Hill MD, Ryckborst KJ, Tamariz D, Ginsberg MD. The ALIAS pilot trial: a dose‐escalation and safety study of albumin therapy for acute ischemic stroke – II: neurologic outcome and efficacy analysis. Stroke 2006; 37: 2107 – 2114.en_US
dc.identifier.citedreferenceGould AL, Shih WJ. Modifying the design of ongoing trials without unblinding. Stat Med 1998; 17: 89 – 100.en_US
dc.identifier.citedreferenceO'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979; 35: 549 – 556.en_US
dc.identifier.citedreferenceLan KKG, Demets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983; 70: 659 – 663.en_US
dc.identifier.citedreferenceGentile NT, Seftchick MW, Huynh T, Kruus LK, Gaughan J. Decreased mortality by normalizing blood glucose after acute ischemic stroke. Acad Emerg Med 2006; 13: 174 – 180.en_US
dc.identifier.citedreferenceWilliams LS, Rotich J, Qi R et al. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 2002; 59: 67 – 71.en_US
dc.identifier.citedreferenceKruyt ND, Biessels GJ, Devries JH, Roos YB. Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management. Nat Rev Neurol 2010; 6: 145 – 155.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ijs12045.pdf
Size:
116.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.